---
title: "BeOne Medicines CEO John Oyler disposes of $27,267,619 in common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292692481.md"
description: "BeOne Medicines CEO John Oyler sold 79,200 American Depositary Shares (ADS) valued at approximately $27.3 million between July 10-13. The sales occurred after exercising options for 782,834 ordinary shares at $2.84 per share. Following these transactions, Oyler's direct ADS holdings dropped to zero. The weighted-average sale price ranged from USD 296.07 to 307.41 per ADS."
datetime: "2026-07-15T01:26:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292692481.md)
  - [en](https://longbridge.com/en/news/292692481.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292692481.md)
generator: "portal-rs"
---

# BeOne Medicines CEO John Oyler disposes of $27,267,619 in common shares

-   BeOne Medicines CEO John Oyler reported option exercises on July 10-13, then sold the resulting American Depositary Shares. \* Disposed of 79,200 ADS in total at weighted-average prices near USD 296.07-307.41 per ADS. \* Directly held ADS position fell to zero following the sales. \* Exercised options for 782,834 ordinary shares at an exercise price of USD 2.84 per share. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeOne Medicines AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001042047-26-000011), on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)

## Related News & Research

- [Aaron Rosenberg Implements A Sell Strategy: Offloads $361K In BeOne Medicines Stock](https://longbridge.com/en/news/295122313.md)
- [BeOne Medicines SVP, General Counsel Chan Henry Lee sells 1,669 ADS for $542,425 under 10b5-1 plan](https://longbridge.com/en/news/293796647.md)
- [MEDI: Record sales, high margins, and upgraded growth outlook driven by strong global demand](https://longbridge.com/en/news/296593258.md)
- [MEDI: Record sales and profit in Q2/H1 2026, with strong growth in own products and key regions](https://longbridge.com/en/news/296576263.md)
- [BeOne Medicines (ONC) Could Be 25% Undervalued As MANGROVE Trial Data Lands](https://longbridge.com/en/news/292031731.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**